Dow has reached a final investment decision (FID) to proceed with its US alkoxylates capacity expansion, its CEO said on Thursday.
“This US Gulf Coast unit is expected to start up by the end of 2021. Furthermore, we recently signed a 10-year supply agreement with a key customer securing the baseload volume for this facility, representing $900m of new revenue over the life of the contract,” said Dow CEO Jim Fitterling, on the company’s Q3 earnings conference call.
The expansion will support Dow customers’ growth in infrastructure, and home and personal care end markets, he noted.
Planned capacity of the unit was not disclosed.
The flexible alkoxylation project was listed among Dow’s growth projects during its pre-spin roadshow in March 2019 with a planned start-up in the first half of 2020.
By Joseph Chang
Source: ICIS News
LinkedIn Twitter FacebookEvonik Industries AG has concluded a purchase agreement to acquire Wilshire Technologies Inc., with the transaction to be completed by the end of January. Headquartered in Princeton N.J., […]
LinkedIn Twitter FacebookChina’s petrochemical industry is on the start of a downcycle, according to Wood Mackenzie, as a supply overhang in the paraxylene (PX) market looks set to be joined […]
LinkedIn Twitter FacebookGerman specialty chemicals company Lanxess has completed the sale of its chrome chemicals business to Chinese leather chemicals producer Brother Enterprises for €80m ($89m). The deal was first […]